AI + Healthcare: Championing Real-World Success and Charting a New Future
June 15, 2022, 7:30 - 9:30 AM PDT
Exact location disclosed after registration confirmation — Sign Up Now!
There is a storied history of AI and healthcare. But, where did we start? Where are we now? Where are we going? We no longer have to wonder about the potential of AI – but rather celebrate its achievements end-to-end with AI/ML integration across the life science and healthcare spectrum and envision a new future.
This panel moves beyond the hype to examine the real-world successes of AI in healthcare and investigates the path for FDA-approved drugs and diagnostics, which strategies are being used at which phase, from preclinical to clinical, and how partnerships are being implemented in clinical development.
Panelists:
Stacie Calad-Thomson - Chief Strategy Officer and Head of Drug Discovery, BioSymetrics
Matt Kinn - Vice President of Business Development and Corporate Initiatives, Recursion
Michael Kremliovsky - Senior Director, Medical Devices and eHealth, Bayer
Dimitrios Skaltsas - Co-Founder and Executive Director, Intelligencia
Moderator: John Piccone - Principal, Biomedical Research, ZS Consulting
With opening remarks from Naheed Kurji, Chairperson of AAIH and CEO of Cyclica.